台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    109.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    76
  • 產業
    上櫃 生技醫療類股
  • 41人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
共信-KY (6617)籌碼相關-兆豐-忠孝 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-忠孝 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/210.1108.5000.00109.500.12040.03%
2024/11/0800.001120.50115.00-1268-0.38%
2024/11/071117.5000.00117.5012660.38%
2024/10/2800.000.2106.50103.00-0.2291-0.07%
2024/10/240.1108.0000.00106.000.12950.03%
2024/10/210.1109.0000.00113.500.13040.03%
2024/10/1400.004108.00109.50-4322-1.24%
2024/10/080.1113.0000.00112.500.13250.03%
2024/10/070113.0000.00112.5003260.00%
2024/09/0500.002131.00126.00-2559-0.36%
2024/09/041133.002128.25133.50-1556-0.18%
2024/09/032.1130.1900.00129.502.15470.38%
2024/08/290132.002132.00131.50-2551-0.36%
2024/08/281131.501132.00133.5005650.00%
2024/08/2700.002125.00127.50-2557-0.36%
2024/08/261128.001124.00125.5005550.00%
2024/08/233129.831134.50126.0025520.36%
2024/08/2200.003125.50129.00-3543-0.55%
2024/08/211115.502.2117.86121.50-1.2528-0.23%
2024/08/201111.500.1113.00113.000.95120.18%
2024/08/160.1101.0000.00101.000.15060.02%
2024/08/152.197.40796.0098.50-4.9502-0.97%
2024/08/132101.0000.00101.0024910.41%
2024/08/090.1102.5000.00102.000.14900.02%
2024/08/061102.0000.00103.5014710.21%
2024/08/051113.0000.00112.0014640.22%
2024/08/021127.0000.00124.0014610.22%
2024/07/291133.0000.00130.0014520.22%
2024/07/181144.5000.00141.0014270.23%
2024/07/1600.001137.50136.00-1416-0.24%
2024/07/151132.5000.00132.5014130.24%
2024/07/050.1140.0000.00139.500.14040.01%
2024/07/041141.5000.00140.0014020.25%
2024/07/0300.001141.50143.00-1393-0.25%
2024/06/2600.001152.50153.00-1357-0.28%
2024/06/2500.002143.00147.50-2342-0.58%
2024/06/2400.001155.00147.00-1329-0.30%
2024/06/213.1157.714155.50160.00-0.9300-0.30%
2024/06/201.1141.231.4140.86146.50-0.3253-0.12%
2024/06/191.1129.0900.00128.501.12140.51%
2024/06/181.1133.0000.00132.001.11990.55%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨-2024/08/24
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨-2024/07/31
共信-KY 相關文章
共信-KY 相關影音